Moderna cancer vaccine shows positive results in melanoma trial
Moderna said its personalized mRNA cancer vaccine lowered the risk of melanoma returning or spreading when used with Keytruda in a late-stage trial.
By the ClickNNY North Country Desk
Moderna said its personalized mRNA cancer vaccine reduced the risk of melanoma returning or spreading in a late-stage trial. The vaccine was tested with Merck’s Keytruda, an immunotherapy treatment, compared with Keytruda alone.
The companies said the treatment could be available as soon as next year if regulators approve it. Because the vaccine is tailored to each patient, producing it on a large scale could be difficult. The results sent Moderna shares sharply higher, with the stock rising as much as 160%.
Reported by ClickNNY and reviewed by an editor before publication.
More from ClickNNY
Guides and features from across the North Country.
ClickNNY Election 2026 · Showdown in Jefferson County
Ousted by his own party, still on the ballot: inside Jefferson County’s three-way fight for power
Knocked off his own party's line in June, an incumbent refuses to quit. A 24-year legislator faces his first opponent in years. And a challenger vows to break up a board with no Democrats. Here's who is fighting for your vote on Nov. 3.
ClickNNY Guide · Community
Protecting hibernating bats in St. Lawrence County: what to know
New York residents, including those in St. Lawrence County, can help protect hibernating bats by avoiding restricted caves and mines, limiting tree removal during the winter, and using trained wildlife professionals for bats in homes.
ClickNNY Special Report · Technology
The Good. The Bad. The Rogue.
AI agents are here, working for us, being used against us and, it appears, sometimes doing what nobody told them to. What it means for North Country jobs, money and privacy, and what is still unanswered.